J9225 HCPCS Level II code: Histrelin implant (vantas), 50 mg
J9225 is the HCPCS code for “Histrelin implant (vantas), 50 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9225Histrelin implant (vantas), 50 mg
Short description: Vantas implant
HCPCS · United States
Medicare details
The indicators CMS publishes with J9225 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2006
Where J9225 sits
- 1J codesDrugs administered other than orally
- 2Active code J9225Histrelin implant (vantas), 50 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9225 mean?
J9225 is the HCPCS code for “Histrelin implant (vantas), 50 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9225?
CMS lists J9225’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9225
All J codesJ9216Injection, interferon, gamma 1-b, 3 million unitsJ9217Leuprolide acetate (for depot suspension), 7.5 mgJ9218Leuprolide acetate, per 1 mgJ9219Leuprolide acetate implant, 65 mgJ9220Injection, indigotindisulfonate sodium, 1 mgJ9223Injection, lurbinectedin, 0.1 mgJ9226Histrelin implant (supprelin la), 50 mgJ9227Injection, isatuximab-irfc, 10 mgJ9228Injection, ipilimumab, 1 mgJ9229Injection, inotuzumab ozogamicin, 0.1 mgJ9230Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mgJ9232Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg